Biotech Decliners: Insmed Incorporated (NASDAQ:INSM), 22nd Century Group Inc (NYSEMKT:XXII), Concert Pharmaceuticals Inc (NYSE:JMPC), Relypsa Inc (NASDAQ:RLYP)

Insmed Incorporated (NASDAQ:INSM) on May 13, 2014 announces that multiple posterpresentations reporting data on ARIKAYCE(TM), or liposomal amakacinfor inhalation, for the treatment of Pseudomonas aeruginosainfections in cystic fibrosis (CF) patients and for the treatment ofpatients with treatment-resistant nontuberculous mycobacterial (NTM)lung infections will be presented at the American Thoracic SocietyAnnual Meeting 2014, taking place May 16-21 in San Diego, California. Insmed Incorporated (NASDAQ:INSM) stock performance was -5.49% in last session and finished the day at $13.09. Traded volume was 867,500 shares in the last session and the average volume of the stock remained 886.60K shares. The beta of the stock remained 0.50. Insmed Incorporated (NASDAQ:INSM) insider ownership is 1.50%.

Investors in 22nd Century Group Inc (NYSEMKT:XXII) saw new options begin trading today, for the January 2015 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 243 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. 22nd Century Group Inc (NYSEMKT:XXII) dropped -7.00% to $2.79 yesterday on volume of 559,800 shares. The intra-day range of the stock was $2.72 – 3.25. 22nd Century Group Inc (NYSEMKT:XXII) has a market capitalization of $163.67 million.

Concert Pharmaceuticals Inc (NYSE:JMPC) fell 5% during trading on Wednesday after the company announced weaker than expected quarterly earnings, Analyst Ratings Net reports. The stock traded as low as $9.30 and last traded at $9.88, with a volume of 78,601 shares changing hands. The stock had previously closed at $10.40. Concert Pharmaceuticals Inc (NYSE:JMPC)’s stock on May 16, 2014 reported a increase of 0.57% to the closing price of $25.46. Its fifty two weeks range is $25.35 – 25.46. The total market capitalization recorded $455.72 million. The overall volume in the last trading session was 230,010 shares. In its share capital, Concert Pharmaceuticals Inc (NYSE:JMPC) has 17.90 million outstanding shares.

Relypsa Inc (NASDAQ:RLYP) continued to rally upwards for the third day in a row with a gain of more than 6% on Tuesday. The stock broke above its trend line resistance level of $21.50 to consolidate at$22.70. On Friday, shares of Relypsa Inc (NASDAQ:RLYP) dropped -5.07% to close the day at $21.55. Company monthly performance is recorded as -5.61%. Relypsa Inc (NASDAQ:RLYP) quarterly revenue growth is -47.44%.